DK1748998T3 - Ny stereoselektiv syntese af benzimidazolsulfoxider - Google Patents

Ny stereoselektiv syntese af benzimidazolsulfoxider

Info

Publication number
DK1748998T3
DK1748998T3 DK04735319.8T DK04735319T DK1748998T3 DK 1748998 T3 DK1748998 T3 DK 1748998T3 DK 04735319 T DK04735319 T DK 04735319T DK 1748998 T3 DK1748998 T3 DK 1748998T3
Authority
DK
Denmark
Prior art keywords
methoxy
benzimidazole
dimethyl
camphorsulfonyl
pyridyl
Prior art date
Application number
DK04735319.8T
Other languages
English (en)
Inventor
Reddy B Parthasaradhi
Reddy Kura Rathnakar
Reddy Rapolu Raji
Reddy D Muralidhara
Original Assignee
Hetero Drugs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Drugs Ltd filed Critical Hetero Drugs Ltd
Application granted granted Critical
Publication of DK1748998T3 publication Critical patent/DK1748998T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
DK04735319.8T 2004-05-28 2004-05-28 Ny stereoselektiv syntese af benzimidazolsulfoxider DK1748998T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IN2004/000143 WO2005116011A1 (en) 2004-05-28 2004-05-28 A novel stereoselective synthesis of benzimidazole sulfoxides
EP04735319A EP1748998B1 (en) 2004-05-28 2004-05-28 A novel stereoselective synthesis of benzimidazole sulfoxides

Publications (1)

Publication Number Publication Date
DK1748998T3 true DK1748998T3 (da) 2010-05-10

Family

ID=35450822

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04735319.8T DK1748998T3 (da) 2004-05-28 2004-05-28 Ny stereoselektiv syntese af benzimidazolsulfoxider

Country Status (8)

Country Link
US (3) US7365206B2 (da)
EP (1) EP1748998B1 (da)
AT (1) ATE456566T1 (da)
DE (1) DE602004025386D1 (da)
DK (1) DK1748998T3 (da)
ES (1) ES2338556T3 (da)
PT (1) PT1748998E (da)
WO (1) WO2005116011A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2528993A1 (en) * 2003-06-10 2004-12-23 Teva Pharmaceutical Industries Ltd. Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
CA2787378C (en) * 2004-09-13 2015-11-03 Takeda Pharmaceutical Company Limited Method for producing lansoprazole crystal
DK1848414T3 (da) 2005-02-03 2011-07-25 Gen Hospital Corp Fremgangsmåde til behandling af gefitinib-resistent cancer
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
WO2008102145A2 (en) 2007-02-21 2008-08-28 Cipla Limited Process for the preparation of esomeprazole magnesium dihydrate
WO2009047775A2 (en) * 2007-10-08 2009-04-16 Hetero Drugs Limited Polymorphs of esomeprazole salts
US8022216B2 (en) * 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
CA2725598C (en) 2008-06-17 2013-10-08 Wyeth Llc Antineoplastic combinations containing hki-272 and vinorelbine
EP2143722A1 (en) * 2008-07-09 2010-01-13 Lek Pharmaceuticals D.D. Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
WO2010058409A2 (en) 2008-11-18 2010-05-27 Hetero Research Foundation Optical purification of esomeprazole
WO2010095144A2 (en) * 2009-02-04 2010-08-26 Msn Laboratories Limited Process for the preparation of proton pump inhibitors
WO2011058569A1 (en) 2009-11-12 2011-05-19 Hetero Research Foundation Process for the resolution of omeprazole
WO2011121594A1 (en) * 2010-04-01 2011-10-06 Neuland Laboratories Ltd. A process for the preparation of itraconazole

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
US5877192A (en) * 1993-05-28 1999-03-02 Astra Aktiebolag Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
CN100396675C (zh) * 1998-08-10 2008-06-25 加利福尼亚州大学董事会 质子泵抑制剂的前药
EP1515963B1 (en) 2002-06-27 2007-02-14 Dr. Reddy's Laboratories Ltd. A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
PT1740571E (pt) * 2004-04-28 2009-09-02 Hetero Drugs Ltd Processo para preparar compostos de piridinilmetil-1hbenzimidazol na forma enantiomericamente enriquecida ou como enantiómeros únicos

Also Published As

Publication number Publication date
PT1748998E (pt) 2010-03-24
WO2005116011A1 (en) 2005-12-08
US8173817B2 (en) 2012-05-08
US20060166986A1 (en) 2006-07-27
US7365206B2 (en) 2008-04-29
EP1748998B1 (en) 2010-01-27
EP1748998A1 (en) 2007-02-07
ATE456566T1 (de) 2010-02-15
ES2338556T3 (es) 2010-05-10
US20080076929A1 (en) 2008-03-27
US7928241B2 (en) 2011-04-19
DE602004025386D1 (de) 2010-03-18
US20080076930A1 (en) 2008-03-27

Similar Documents

Publication Publication Date Title
DK1748998T3 (da) Ny stereoselektiv syntese af benzimidazolsulfoxider
SE9900274D0 (sv) New compound
ME00198B (me) Novi oblik s-omeprazola
MXPA04004464A (es) Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
EE04279B1 (et) Omeprasooli kristalne vorm
ATE548353T1 (de) Verfahren zur herstellung von substituierte n- aryl-n'-ä3-(1h-pyrazol-5-yl)phenylü-harnstoffe and intermediate davon.
MY137040A (en) Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
NO20052474L (no) Amort form av esomeprazolsalter
ES2191944T3 (es) Forma cristalina de la sal de sodio de omeprazol.
ATE465159T1 (de) (s)-(-)-1-(4-fluorisochinolin-5-yl)sulfonyl-2- methyl-1,4-homopiperazinhydrochlorid- dihydrat
CO4750654A1 (es) Proceso para la sintesis de un compuesto omeprazol
DK1740571T3 (da) Fremgangsmåde til fremstilling af pyridinylmethyl-1H-benzimidazolforbindelser i enantiomerisk beriget form eller som enkelte enantiomerer
EA200900985A1 (ru) Способ получения оптически чистого омепразола
ATE354583T1 (de) Verfahren zur herstellung c-7 substituierter 5- androstene
ATE363480T1 (de) Alkylammoniumsalze von omeprazol und esomeprazol
WO2011042910A3 (en) Optical resolution of substituted 2-(2- pyridinylmethylsulphinyl)-1h-benzimidazoles
AR042278A1 (es) Un procedimiento para la preparacion de (s) - pantoprazol
PE20080930A1 (es) 2-imidazoles sustituidos
ATE428707T1 (de) Verfahren zur herstellung des (s)-enantiomers von omeprazol
EA200801591A1 (ru) Антагонисты мускаринового рецептора
DE60335980D1 (de) Verfahren zur herstellung von synthetischen derivaten von dibenzylbutyrolacton-lignanen mit antichagas eigenschaften
SE0400410D0 (sv) New compounds
SE0302381D0 (sv) New salts I
WO2007098393A3 (en) Compounds and methods for treating diseases with trpv4 channel receptors
ATE353887T1 (de) Verfahren zur herstellung optisch reiner oder optisch angereicherter sulfoxidverbindungen einschliesslich amorphen esomeprazols und dessen salze